Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity

On March 27, 2026, BTIG maintained its Buy standing connected Humacyte but chopped its terms people to $3 from $6 aft the institution reported fourth-quarter and full-year 2025 results earlier the aforesaid day. Humacyte reported $0.5 cardinal successful fourth-quarter gross and $2.0 cardinal successful full-year revenue, portion BTIG said the quarterly fig missed its $1.3 cardinal estimate. The expert enactment besides said the institution posted a nonaccomplishment per stock of $0.13, versus statement expectations for a $0.12 loss.

BTIG said the trauma motorboat for Symvess remains choppy connected a quarter-to-quarter basis. The steadfast noted that Humacyte sold astir 25 units successful the 4th quarter, down from astir 29 successful the 3rd 4th of 2025, portion the terms per portion declined to astir $17,000 from astir $24,500. BTIG besides flagged elevated operating expenses and said currency remains a captious focus.

Even so, BTIG pointed to immoderate commercialized progress, with the fig of hospitals ordering Symvess for trauma usage rising to 27 from 16. Humacyte besides said connected March 27 that it received a acquisition committedness for a minimum of $1.475 cardinal for a objective valuation and outreach programme successful Saudi Arabia, portion some the institution and BTIG highlighted interim top-line results from the Phase 3 V012 survey successful dialysis entree expected successful the 2nd 4th of 2026. BTIG said the dialysis entree marketplace represents a larger accidental than the trauma market.

Humacyte, Inc. (NASDAQ:HUMA) is simply a commercial-stage biotechnology level institution processing universally implantable, bioengineered quality tissues astatine commercialized scale.

While we admit the imaginable of HUMA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.